References
- Kearney PM, Whelton M, Reynolds K et al. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217-23.
- Forouzanfar MH, Liu P, Roth GA et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115mmHg, 1990-2015. JAMA. 2017;317(2):165-82.
- Zhou B, Perel P, Mensah GA et al. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol. 2021;18(11):785-802.
- Ettehad D, Emdin CA, Kiran A et al. Blood pressure lowering for prevention of cardiovascular disease and death: A systematic review and meta-analysis. Lancet. 2016;387(10022):957-67.
- Nadar SK, Lip GYH. The heart in hypertension. J Hum Hypertens. 2021;35(5):383-6.
- Dorobantu M, Tautu OF, Dimulescu D et al. Perspectives on hypertension’s prevalence, treatment and control in a high cardiovascular risk East European country: Data from the SEPHAR III survey. J Hypertens. 2018;36(3):690-700.
- Dorobanţu M, Darabont R, Ghiorghe S et al. Hypertension prevalence and control in Romania at a seven-year interval. Comparison of SEPHAR I and II surveys. J Hypertens. 2014;32(1):39-47.
- Williams B, Mancia G, Spiering W et al. 2018 ESC/ESH Guidelines for themanagement of arterial hypertension. Eur Heart J. 2018; 39:3021-310.
- Lang RM, Badano LP, Mor-Avi V et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American society of echocardiography and the European association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging. 2015;16(3):233- 71.
- Nagueh SF, Smiseth OA, Appleton CP et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29(4):277-314.
- Guo G, Wang H, Bell D et al. KNN model-based approach in classification. Lect Notes Comput Sci. 2003;2888:986-96.
- Buuren S van, Oudshoorn K. Flexible multivariate imputation by MICE. TNO Prev Heal. 1999;1-20.
- Dempster AP, Laird NM, Rubin DB. Maximum Likelihood from Incomplete Data Via the EM Algorithm. J R Stat Soc Ser B. 1977;39(1):1-22.
- https://scikit-learn.org/stable/modules/generated/sklearn.impute. IterativeImputer.html
- Bießmann F, Rukat T, Schmidt P et al. DataWig: Missing value imputation for tables. J Mach Learn Res. 2019;20:1-6.
- Correll RN, Eder P, Burr AR et al. Overexpression of the Na+/K+ ATPase α2 but not α1 isoform attenuates pathological cardiac hypertrophy and remodelling. Circ Res. 2014;114(2):249-56.
- Schlaich MP, Kaye DM, Lambert E et al. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation. 2003;108(5):560-5.
- Ichikawa KI, Hidai C, Okuda C et al. Endogenous endothelin-1 mediates cardiac hypertrophy and switching of myosin heavy chain gene expression in rat ventricular myocardium. J Am Coll Cardiol. 1996;27(5):1286-91.
- Seko Y, Kato T, Shiba M et al. Staging cardiac damage in patients with hypertension. Hypertension. 2019;74(6):1357-65.
- Marwick TH, Gillebert TC, Aurigemma G et al. Recommendations on the use of echocardiography in adult hypertension: A report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE). Eur Heart J Cardiovasc Imaging. 2015;16(6):577-605.
- Milani RV, Lavie CJ, Mehra MR et al. Left ventricular geometry and survival in patients with normal left ventricular ejection fraction. Am J Cardiol. 2006;97:959-63.
- Koren MJ, Devereux RB, Casale PN et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991;114(5):345-52.
- Cuspidi C, Sala C, Negri F et al. Prevalence of left-ventricular hypertrophy in hypertension: An updated review of echocardiographic studies. J Hum Hypertens. 2012;26(6):343-9.
- Cramariuc D, Gerdts E. Epidemiology of left ventricular hypertrophy in hypertension: implications for the clinic. Expert Rev Cardiovasc Ther. 2016;14(8):915-26.
- Levy D, Savage DD, Garrison RJ et al. Echocardiographic criteria for left ventricular hypertrophy: The Framingham heart study. Am J Cardiol. 1987;59(9):956-60.
- Gerdts E, Izzo R, Mancusi C et al. Left ventricular hypertrophy offsets the sex difference in cardiovascular risk. Int J Cardiol. 2018;258:257-61.
- Ruilope LM, Schmieder RE. Left ventricular hypertrophy and clinical outcomes in hypertensive patients. Am J Hypertens. 2008;21(5):500-8.
- Li H, Pei F, Shao L et al. Prevalence and risk factors of abnormal left ventricular geometrical patterns in untreated hypertensive patients. BMC Cardiovasc Disord. 2014;14(1):1-7.
- Ngabea MA, Ojji DB, Umar H et al. Prevalence of echocardiographic left ventricular hypertrophy among hypertensives in a tertiary health institution in Nigeria. Ann Med Res Pract. 2022;3(3):1–5.
- Dorobantu M, Vijiiac A, Scafa-Udriste A et al.. Cardiac damage in hypertensive patients.The Romanian experience. AρτηρIακη Yρρδαραση. 2021;30(2):100–4.
- Kuznetsova T, Herbots L, López B et al. Prevalence of left ventricular diastolic dysfunction in a general population. Circ Hear Fail. 2009;2(2):105– 12.
- Kloch-Badelek M, Kuznetsova T, Sakiewicz W et al. Prevalence of left ventricular diastolic dysfunction in European populations based on crossvalidated diagnostic thresholds. Cardiovasc Ultrasound. 2012;10(1):1–9.
- Pavlopoulos H, Grapsa J, Stefanadi E et al. The evolution of diastolic dysfunction in the hypertensive disease. Eur J Echocardiogr. 2008;9(6):772–8.
- Zhou D, Yan M, Cheng Q et al. Prevalence and prognosis of left ventricular diastolic dysfunction in community hypertension patients. BMC Cardiovasc Disord. 2022;22(1):1–9.
- Al-Ghamdi S, Alzubaidi FK, Alharthai SA et al. Prevalence and correlates of diastolic dysfunction in patients with hypertension: A cross-sectional study from in the kingdom of Saudi Arabia. Pan Afr Med J. 2021;40:159.
- Leão RN, da Silva PM, Pocinho RM et al. Determinants of left ventricular diastolic dysfunction in hypertensive patients. Hipertens y Riesgo Vasc. 2018;35(4):160–8.
- Świerblewska E, Wolf J, Kunicka K et al. Prevalence and distribution of left ventricular diastolic dysfunction in treated patients with long-lasting hypertension. Blood Press. 2018;27(6):376–84.
- Vasan RS, Xanthakis V, Lyass A et al. Epidemiology of Left Ventricular Systolic Dysfunction and Heart Failure in the Framingham Study: An Echocardiographic Study Over 3 Decades. JACC Cardiovasc Imaging. 2018;11(1):1–11.
- van Riet EES, Hoes AW, Wagenaar KP et al. Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review. Eur J Heart Fail. 2016;18:242–52.
- Messerli FH, Rimoldi SF, Bangalore S. The Transition From Hypertension to Heart Failure: Contemporary Update. JACC Hear Fail. 2017;5(8):543–51.
- Verdecchia P, Angeli F, Gattobigio R et al. Asymptomatic left ventricular systolic dysfunction in essential hypertension: Prevalence, determinants, and prognostic value. Hypertension. 2005;45(3):412–8.
- Ojji D, Atherton J, Sliwa K et al. Left ventricular systolic dysfunction in asymptomatic black hypertensive subjects. Am J Hypertens. 2015;28(7):924-9
- Mitsutake R, Miura SI, Shiga Y et al. Association Between Hypertension and Coronary Artery Disease as Assessed by Coronary Computed Tomography. J Clin Hypertens. 2011;13(3):198–204.